Menu
Program Areas

Technology

Unlocking the full potential of CRISPR genome editing requires continuous innovation.

We need more options for safely and reliably delivering editing tools into agricultural crops and the parts of the human body that are harmed by mutations. The IGI is developing cross-cutting new approaches to accelerate development and delivery of therapeutics, agricultural engineering, and scientific discovery. We are building upon foundational CRISPR-Cas technologies to create more precise and powerful tools for manipulating the genome.

21

Principal Investigators

16

Research Projects

25

Published Papers

Key Goals

Develop new ways to deliver CRISPR components to specific cells and tissues
Analyze and enhance the performance of existing genome editing methods
Create new CRISPR-Cas technologies, from new Cas effectors to new functions

Technology Projects